Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/11/21
Dare Bioscience, Inc. (DARE) Reports Q3 Loss, Lags Revenue EstimatesZacks Investment Research • 11/10/21
Daré Bioscience Reports Third Quarter 2021 Financial Results and Provides a Company UpdateGlobeNewsWire • 11/10/21
Daré Bioscience to Participate in Panel Discussion at DTC Perspectives' Xpectives.Health Summit, October 12-14, 2021GlobeNewsWire • 10/06/21
Daré Bioscience Announces NIH Grant Award to Support Development of DARE-LARC1GlobeNewsWire • 09/27/21
Daré Bioscience to Present at the 2021 Cantor Virtual Global Healthcare ConferenceGlobeNewsWire • 09/22/21
Daré Bioscience to Participate in H.C. Wainwright 23rd Annual Global Investment ConferenceGlobeNewsWire • 09/08/21
Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/13/21
Daré Bioscience Reports Second Quarter 2021 Financial Results and Provides a Company UpdateGlobeNewsWire • 08/12/21
Daré Bioscience Stock Is Trading Higher As Bacterial Vaginosis Candidate Secures FDA Priority ReviewBenzinga • 08/09/21
Daré Bioscience to Host Second Quarter 2021 Financial Results and Company Update Conference Call and Webcast on August 12, 2021GlobeNewsWire • 08/05/21